Clinical trial · Interventional
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
Short Term Magnetic Resonance Imaging (MRI) for Treatment Response Evaluation and Prognosis Prediction in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Radioembolization (TARE)
NCT03731910CI-TRIAL-00055573unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to investigate the value of early change at MRI in HCC treated with TARE, for evaluation/prediction of treatment response and prognosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRI | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HCC group
- description
- Participants who are scheduled for TARE for HCC treatment. They undergo MRI three times- before, 1- and 2-week after TARE.
- interventionNames
- Diagnostic Test: MRI
Primary outcomes (1)
- measure
- Treatment response mRECIST
- timeFrame
- 1 month after last MRI
- description
- treatment response using mRECIST
Secondary outcomes (5)
- measure
- Tumor diffusion
- timeFrame
- 1 months after last MRI
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Intermediate or locally advanced HCC according to Hong Kong Liver Cancer guideline * Scheduled for transarterial radioembolization (TARE) * sign informed consent Exclusion Criteria: * Any absolute or relative contra-indication of contrast-enhanced MRI * History of other local treatment before TARE in 3 weeks
References
Publications (0)
Data not yet available
No reference posted for this study.